Galenica AG

Pharmaceuticals
Switzerland
Executive 1Dr. David R. Ebsworth, Ph.D., Chief Executive Officer; Division Officer; Head | Chief Executive Officer; Division Officer; Head
Executive 2Dr. Joerg Kneubuehler, Chief Financial Officer; Head | Chief Financial Officer; Vice President
Earnings Per Share Growth (%)-3.92%
Cost of Goods Sold (US$ Millions)$2,209
Current Liabilities (US$ Millions)$692
Total Assets (US$ Millions)$1,316
Long Term Debt (Millions)$615
Return on Equity20.72%
Revenue (US$ Millions)$3,711
Total Company Assets$3,243
Revenue Growth (%)0.18%
Net Income (US$ Millions)$315
Earnings Per Share (US$)$44.32
Total Equity (US$ Millions)$1,731
Profit Margin (%)8.50%
Debt To Equity Ratio (%)0.36%
Inventories (Millions)$380